Carlsmed (CARL) Short-term Investments (2024 - 2026)

Carlsmed (CARL) has reported Short-term Investments for 3 consecutive years, with $24.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Short-term Investments rose 23900.0% year-over-year to $24.0 million; the trailing twelve-month figure through Jun 2026 stood at $24.0 million (up 23900.0% YoY), and the FY2025 full-year result was $24.0 million, up 23900.0% from the prior year.
• Short-term Investments held at $24.0 million in Q2 2026 per CARL's latest filing, from $24.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $24.0 million in Q4 2025 and bottomed at $100000.0 in Q4 2024.
• Historically, Short-term Investments has averaged $12.0 million across 3 years, with a median of $12.0 million in 2024.
• The widest YoY moves for Short-term Investments: up 23900.0% in 2025, down 23900.0% in 2025.
• Over 3 years, Short-term Investments stood at $100000.0 in 2024, then soared by 23900.0% to $24.0 million in 2025, then changed by 0.0% to $24.0 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $24.0 million, $24.0 million, and $24.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.